Go to main content

Thiazolidinediones (TZDs)

Clinical Trials: ADOPT and CHICAGO

Two important studies on thiazolidinediones (TZDs), a class of insulin sensitizers, were published in November and December of 2006. 

Dismantling Avandia, Actos and the TZDs

Dismantling Avandia, Actos and TZDs.

American Diabetes Association 68th Scientific Sessions – San Francisco (June 6-10)

When every fifth taxi in downtown San Francisco is carrying an ad for Byetta, FlexPen, or FreeStyle meters, you know the American Diabetes Association (ADA) is in town. 

FDA Updates Warnings and Precautions Section of Actos Label after French and German Regulatory Authorities Suspend Drug Due to Possible Increased Risk of Bladder Cancer

Diabetes Care in the United States – An Interview with Noted Cardiologist Dr. Steven Nissen

Noted cardiologist, Dr. Nissen on Avandia.

ACCORD, ADVANCE, and the VADT: What Do They Mean, and for Whom?

ACCORD, ADVANCE, and the VADT: What Do They Mean, And For Whom?